Cara Therapeutics, Inc. ( CARA) - Key Metrics
Stock symbol CARA is outdated, potentially delisted? Maybe it is available on other exchange?
CARA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.05 | -$0.23 | -$0.25 | -$0.25 |
| 2024Q2 | $0.02 | -$0.37 | -$0.23 | -$0.23 |
| 2024Q1 | $0.04 | -$0.56 | -$0.56 | -$0.57 |
| 2023Q4 | $0.06 | -$0.59 | -$0.32 | -$0.36 |
| 2023Q3 | $0.09 | -$0.52 | -$0.36 | -$0.37 |
CARA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -4.07 |
| 2024Q2 | ? | -2.16 |
| 2024Q1 | ? | -4.85 |
| 2023Q4 | ? | -3.76 |
| 2023Q3 | ? | -9.75 |
CARA
Price: $5.32
52 week price:
Earnings Per Share: -15.53 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 393100
Ebitda: -12.8 millionMarket Capitalization: 22.6 million